BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit
Source: SeekingAlpha
2026-01-14 01:35:20 ET
More on BriaCell Therapeutics Corp.
- Seeking Alpha’s Quant Rating on BriaCell Therapeutics Corp.
- Financial information for BriaCell Therapeutics Corp.
Read the full article on Seeking Alpha
For further details see:
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit
BriaCell Therapeutics Corp.
NASDAQ: BCTX
BCTX Trading
2.36% G/L:
$3.90 Last:
148,079 Volume:
$3.80 Open:
BCTX Latest News
February 18, 2026 05:30:00 pm
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
January 28, 2026 07:30:00 am
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
January 27, 2026 07:30:00 am
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
BCTX Stock Data
$7,949,258
1,869,965
4.85%
18
N/A
Biotechnology & Life Sciences
Healthcare
CA
West Vancouver
